These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 34589896)
21. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
22. Systemic Lupus Erythematosus With Isolated Psychiatric Symptoms and Antinuclear Antibody Detection in the Cerebrospinal Fluid. Lüngen EM; Maier V; Venhoff N; Salzer U; Dersch R; Berger B; Riering AN; Nickel K; Fiebich BL; Süß P; Maier SJ; Egger K; Tebartz van Elst L; Endres D Front Psychiatry; 2019; 10():226. PubMed ID: 31105597 [No Abstract] [Full Text] [Related]
23. [Psychiatric symptoms of a paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: A case report]. Le Foll J; Pelletier A Encephale; 2010 Apr; 36(2):166-71. PubMed ID: 20434635 [TBL] [Abstract][Full Text] [Related]
24. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Al-Diwani A; Handel A; Townsend L; Pollak T; Leite MI; Harrison PJ; Lennox BR; Okai D; Manohar SG; Irani SR Lancet Psychiatry; 2019 Mar; 6(3):235-246. PubMed ID: 30765329 [TBL] [Abstract][Full Text] [Related]
25. Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Herken J; Prüss H Front Psychiatry; 2017; 8():25. PubMed ID: 28261116 [TBL] [Abstract][Full Text] [Related]
26. Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review. Hansen N; Bartels C; Teegen B; Wiltfang J; Malchow B Front Immunol; 2022; 13():829058. PubMed ID: 35222413 [TBL] [Abstract][Full Text] [Related]
28. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922 [TBL] [Abstract][Full Text] [Related]
29. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. Levite M J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016 [TBL] [Abstract][Full Text] [Related]
30. Novel anti-cytoplasmic antibodies in cerebrospinal fluid and serum of patients with chronic severe mental disorders. Endres D; Pankratz B; Thiem S; Runge K; Schlump A; Feige B; Nickel K; Reisert M; Mast H; Urbach H; Schiele MA; Domschke K; Berger B; Venhoff N; Prüss H; Tebartz van Elst L World J Biol Psychiatry; 2022 Dec; 23(10):794-801. PubMed ID: 35168497 [TBL] [Abstract][Full Text] [Related]